CALGARY, AB / ACCESSWIRE / April 15, 2020 / This press release is being disseminated as required by National Instrument 62-103 – The Early Warning System and Take over Bid and Insider Reporting Issues regarding the disposition and acquisition of securities of CanadaBis Capital Inc. (“CanadaBis”).
On April 15, 2020, Travis and Kimberley McIntyre (“McIntyre’s”), jointly disposed of 4,401,329 Common shares of CanadaBis at $0.05 per share for proceeds of $220,066. Prior to the disposition, the McIntyre’s held 78,260,200 common shares or 63.5% of the issued and outstanding share of CanadaBis. Following the disposition, the McIntyre’s held 73,858,871 common shares or 60% of the issued and outstanding shares of CanadaBis. The McIntyre’s may in the future acquire additional shares for investment purposes or decrease their beneficial ownership of the securities of CanadaBis.
A copy of the early warning report will be available on CanadaBis Capital Corp.’s Sedar profile at www.sedar.com.
SOURCE: Travis and Kimberley McIntyre
View source version on accesswire.com:
https://www.accesswire.com/585306/Early-Warning-Report-Shares-of-Canadabis-Capital-Corp
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…